At 8.2% CAGR Gunshot Injuries Treatment Market to Hit Remarkable Value By 2025

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global gunshot injuries treatment market was evaluated at US$ 6.9 million in 2015 and is estimated to exhibit a CAGR of 8.2% over the forecast period (2017-2025). Technological advancements, such as innovative pocket-sized devices, aid in emergency treatments in the battlefields for soldiers. Hence, this is one of the major factors driving the expansion of the global gunshot injuries treatment market. Efficient treatment using products that prevent postpartum hemorrhage is another significant factor bolstering the global market growth. Postpartum hemorrhage (PPH), for the record, is the chief cause behind maternal mortality in low-income countries, and account for a quarter of the global maternal deaths.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/772

In an article published by Medscape, the pregnancy-related mortality ratio in 2013 was evaluated at 17.3 deaths per 100,000 pregnant women, and around 11.4% of these deaths were found to be caused by postpartum hemorrhage. At present, several organizations, including the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the UK Government, are known to be financially supporting the development of preventive devices for PPH, which acts as a developmental factor for the global market growth. For instance, the XSTAT-PPH device by jointly developed by the Oregon Health & Science Univsersity and RevMedx for the treatment of PPH in low resource settings, drives the growth of the global gunshot injuries treatment market.

However, surgical priorities for the management of gunshot injuries include hemorrhage control, prevention, and reconstruction of infection. The Xstat syringe was the only FDA-approved device for immediate treatment of blood flow. In 2015, the article published in Current Reviews in Musculoskeletal Medicine stated that around 70% of battlefield wounds that have sustained since the Second World War are gunshot injuries. Therefore, the affected soldiers require immediate admission into trauma centers for definitive management of the gunshot wounds in emergency departments.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/772

Key Market Takeaways:

• The global gunshot injuries treatment market is poised to witness a tremendous CAGR of 8.2% over the forecast period, with the global regions, including Asia Pacific, Latin America, the Middle East, and Africa, focusing on increasing their military spending.
• In the present day, RevMedx, Inc. is the sole player involved in the global gunshot injuries treatment market.

Table of Content

Global Gunshot Injuries Treatment Market Research Report
Section 1: Global Gunshot Injuries Treatment Industry Overview
Section 2: Global Economic Impact on Gunshot Injuries Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Gunshot Injuries Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Gunshot Injuries Treatment Market Forecast

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/gunshot-injuries-treatment-market-772

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837